Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency

Goro Sasaki, Tomohiro Ishii, Naoaki Hori, Naoko Amano, Keiko Homma, Seiji Sato, Tomonobu Hasegawa

Research output: Contribution to journalArticle

Abstract

Steroid 5α-reductase type 2 deficiency (5αRD2) is a congenital disorder of sex development caused by impairment of conversion from testosterone (T) to 5α-dihydrotestosterone (DHT). DHT deficiency leads to various degrees of undervirilized external genitalia including micropenis, primarily correlated with mutations of the SRD5A2 gene that encodes 5α-reductase type 2. Four Japanese boys with isolated micropenis were diagnosed as 5αRD2 by elevated ratios of serum T/ DHT, and decreased ratios of urinary 5a/5β-reduced steroid metabolites. Genetic analyses for SRD5A2 identified that the four patients shared a hypomorphic mutation R227Q that has a residual activity related to the mild-form of 5αRD2. For prepubertal micropenis, DHT was transdermally applied to the four patients at the ages of 4-11 year, increasing a median of stretched penile lengths (SPLs) from 2.6 cm (-2.5 SD) to 4.4 cm (-0.2 SD). Nevertheless, the post-pubertal penile growth was apparently retarded, despite normal levels of T secreted from well-developed testes. The second course of DHT treatment underwent at ages of 12-18 year, but unable to normalize SPLs at a range of 6.0 to 7.0 cm (-3.4 to -2.4 SD). The prostate volumes of two patients were variable at 8.1 and 21 cm3, and a sperm cell count of one patient was normal as young adult. DHT treatment contributes to development of the penis and prostate, which are favorable for the potential fertility of 5aRD2 adults. Meanwhile, the retarded penile growth and a risk of prostate overgrowth may complicate the post-pubertal management with DHT for 5αRD2 males.

Original languageEnglish
Pages (from-to)837-842
Number of pages6
JournalEndocrine journal
Volume66
Issue number9
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Dihydrotestosterone
Oxidoreductases
Prostate
Therapeutics
Steroids
Disorders of Sex Development
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mutation
Sperm Count
Genitalia
Penis
Growth
Fertility
Testosterone
Testis
Young Adult
Cell Count
Serum
Genes
Penis agenesis

Keywords

  • 5α-reductase
  • Dihydrotestosterone
  • Micropenis
  • Prostate
  • SRD5A2

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency. / Sasaki, Goro; Ishii, Tomohiro; Hori, Naoaki; Amano, Naoko; Homma, Keiko; Sato, Seiji; Hasegawa, Tomonobu.

In: Endocrine journal, Vol. 66, No. 9, 01.01.2019, p. 837-842.

Research output: Contribution to journalArticle

Sasaki, Goro ; Ishii, Tomohiro ; Hori, Naoaki ; Amano, Naoko ; Homma, Keiko ; Sato, Seiji ; Hasegawa, Tomonobu. / Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency. In: Endocrine journal. 2019 ; Vol. 66, No. 9. pp. 837-842.
@article{671ed877f0cd430094891efdb120077a,
title = "Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency",
abstract = "Steroid 5α-reductase type 2 deficiency (5αRD2) is a congenital disorder of sex development caused by impairment of conversion from testosterone (T) to 5α-dihydrotestosterone (DHT). DHT deficiency leads to various degrees of undervirilized external genitalia including micropenis, primarily correlated with mutations of the SRD5A2 gene that encodes 5α-reductase type 2. Four Japanese boys with isolated micropenis were diagnosed as 5αRD2 by elevated ratios of serum T/ DHT, and decreased ratios of urinary 5a/5β-reduced steroid metabolites. Genetic analyses for SRD5A2 identified that the four patients shared a hypomorphic mutation R227Q that has a residual activity related to the mild-form of 5αRD2. For prepubertal micropenis, DHT was transdermally applied to the four patients at the ages of 4-11 year, increasing a median of stretched penile lengths (SPLs) from 2.6 cm (-2.5 SD) to 4.4 cm (-0.2 SD). Nevertheless, the post-pubertal penile growth was apparently retarded, despite normal levels of T secreted from well-developed testes. The second course of DHT treatment underwent at ages of 12-18 year, but unable to normalize SPLs at a range of 6.0 to 7.0 cm (-3.4 to -2.4 SD). The prostate volumes of two patients were variable at 8.1 and 21 cm3, and a sperm cell count of one patient was normal as young adult. DHT treatment contributes to development of the penis and prostate, which are favorable for the potential fertility of 5aRD2 adults. Meanwhile, the retarded penile growth and a risk of prostate overgrowth may complicate the post-pubertal management with DHT for 5αRD2 males.",
keywords = "5α-reductase, Dihydrotestosterone, Micropenis, Prostate, SRD5A2",
author = "Goro Sasaki and Tomohiro Ishii and Naoaki Hori and Naoko Amano and Keiko Homma and Seiji Sato and Tomonobu Hasegawa",
year = "2019",
month = "1",
day = "1",
doi = "10.1507/endocrj.EJ19-0111",
language = "English",
volume = "66",
pages = "837--842",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency

AU - Sasaki, Goro

AU - Ishii, Tomohiro

AU - Hori, Naoaki

AU - Amano, Naoko

AU - Homma, Keiko

AU - Sato, Seiji

AU - Hasegawa, Tomonobu

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Steroid 5α-reductase type 2 deficiency (5αRD2) is a congenital disorder of sex development caused by impairment of conversion from testosterone (T) to 5α-dihydrotestosterone (DHT). DHT deficiency leads to various degrees of undervirilized external genitalia including micropenis, primarily correlated with mutations of the SRD5A2 gene that encodes 5α-reductase type 2. Four Japanese boys with isolated micropenis were diagnosed as 5αRD2 by elevated ratios of serum T/ DHT, and decreased ratios of urinary 5a/5β-reduced steroid metabolites. Genetic analyses for SRD5A2 identified that the four patients shared a hypomorphic mutation R227Q that has a residual activity related to the mild-form of 5αRD2. For prepubertal micropenis, DHT was transdermally applied to the four patients at the ages of 4-11 year, increasing a median of stretched penile lengths (SPLs) from 2.6 cm (-2.5 SD) to 4.4 cm (-0.2 SD). Nevertheless, the post-pubertal penile growth was apparently retarded, despite normal levels of T secreted from well-developed testes. The second course of DHT treatment underwent at ages of 12-18 year, but unable to normalize SPLs at a range of 6.0 to 7.0 cm (-3.4 to -2.4 SD). The prostate volumes of two patients were variable at 8.1 and 21 cm3, and a sperm cell count of one patient was normal as young adult. DHT treatment contributes to development of the penis and prostate, which are favorable for the potential fertility of 5aRD2 adults. Meanwhile, the retarded penile growth and a risk of prostate overgrowth may complicate the post-pubertal management with DHT for 5αRD2 males.

AB - Steroid 5α-reductase type 2 deficiency (5αRD2) is a congenital disorder of sex development caused by impairment of conversion from testosterone (T) to 5α-dihydrotestosterone (DHT). DHT deficiency leads to various degrees of undervirilized external genitalia including micropenis, primarily correlated with mutations of the SRD5A2 gene that encodes 5α-reductase type 2. Four Japanese boys with isolated micropenis were diagnosed as 5αRD2 by elevated ratios of serum T/ DHT, and decreased ratios of urinary 5a/5β-reduced steroid metabolites. Genetic analyses for SRD5A2 identified that the four patients shared a hypomorphic mutation R227Q that has a residual activity related to the mild-form of 5αRD2. For prepubertal micropenis, DHT was transdermally applied to the four patients at the ages of 4-11 year, increasing a median of stretched penile lengths (SPLs) from 2.6 cm (-2.5 SD) to 4.4 cm (-0.2 SD). Nevertheless, the post-pubertal penile growth was apparently retarded, despite normal levels of T secreted from well-developed testes. The second course of DHT treatment underwent at ages of 12-18 year, but unable to normalize SPLs at a range of 6.0 to 7.0 cm (-3.4 to -2.4 SD). The prostate volumes of two patients were variable at 8.1 and 21 cm3, and a sperm cell count of one patient was normal as young adult. DHT treatment contributes to development of the penis and prostate, which are favorable for the potential fertility of 5aRD2 adults. Meanwhile, the retarded penile growth and a risk of prostate overgrowth may complicate the post-pubertal management with DHT for 5αRD2 males.

KW - 5α-reductase

KW - Dihydrotestosterone

KW - Micropenis

KW - Prostate

KW - SRD5A2

UR - http://www.scopus.com/inward/record.url?scp=85072747306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072747306&partnerID=8YFLogxK

U2 - 10.1507/endocrj.EJ19-0111

DO - 10.1507/endocrj.EJ19-0111

M3 - Article

C2 - 31178538

AN - SCOPUS:85072747306

VL - 66

SP - 837

EP - 842

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 9

ER -